Vimarsana
Biggest News Aggregation in the World

Page 42 - Neuronetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neuronetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neuronetics Inc Today - Breaking & Trending Today

Neuronetics: Q4 Earnings Insights - Vimarsana News

Neuronetics: Q4 Earnings Insights

Company's 52-week low was at $1.25 Price action over last quarter: Up 189.67% Company Description Neuronetics Inc is a commercial stage medical technology company. It is focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. The company's product the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific area...

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABUS) - The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings - Vimarsana News

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABUS) - The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings

Axsome Therapeutics Inc (NASDAQ: AXSM) (before the market open) Amicus Therapeutics, Inc. (NASDAQ: FOLD) (before the market open) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN) (before the market open) Athenex Inc (NASDAQ: ATNX) (before the market open) Agile Therapeutics Inc (NASDAQ: AGRX) (after the close) Atara Biotherapeutics Inc (NASDAQ: ATRA) (after the close) Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) (after the close) Adverum Biotechnologies Inc (NASDAQ: ADVM) (after the close) Omeros Corporation (NASDAQ: OMER) (after the close) ChemoCentryx Inc (NASDAQ: CCXI) (after the c...

Neuronetics to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & ... - Vimarsana News

Neuronetics to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Neuronetics to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & ... NeuroneticsFebruary 10, 2021 GMT MALVERN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that Keith Sullivan, President and Chief Executive Officer, and Steve Furlong, Chief Financial...

Source: apnews.com
Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock - Vimarsana News

Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock NeuroneticsJanuary 29, 2021 GMT MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it has priced the previously announced underwritten public offering of 4,840,000 shar...

Source: apnews.com
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results - Vimarsana News

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results MALVERN, Pa., Jan. 12, 2021 — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today, in advance of the ICR/Westwicke Conference, announced certain preliminary unaudited fourth quarter and full year 2020 revenue results. Fourth Quarter 2020 Fourth quar...